This report is not a personal recommendation and does not take into account your personal circumstances or appetite for risk.
| Yesterday’s UK 100 Leaders | Price (p) | % Chg |
| CARNIVAL PLC | 3,587.0 | 6.8% |
| RECKITT BENCKISER GROUP PLC | 6,180.0 | 3.5% |
| SCOTTISH MORTGAGE INV TR PLC | 572.5 | 2.5% |
| HISCOX LTD | 1,419.0 | 2.5% |
| ASTRAZENECA PLC | 7,808.0 | 2.3% |
| Yesterday’s UK 100 Laggards | Price (p) | % Chg |
| NMC HEALTH PLC | 1300.5 | ##### |
| BARCLAYS PLC | 178.4 | -2.7% |
| LLOYDS BANKING GROUP PLC | 62.3 | -2.5% |
| LAND SECURITIES GROUP PLC | 942.6 | -2.1% |
| STANDARD CHARTERED PLC | 723.2 | -2.1% |
| Major World Indices | Price | % Chg | 1 Year |
| UK 100 INDEX | 7,582 | 0.1% | 12.8% |
| DOW JONES INDUS. AVG | 28,455 | 0.3% | 26.8% |
| DAX INDEX | 13,319 | 0.8% | 25.3% |
| NIKKEI 225 | 23,821 | 0.0% | 18.1% |
| S&P/ASX 200 INDEX | 6,785 | -0.5% | 24.1% |
| Commodities | Units | Price | % Chg |
| WTI Crude Oil (Nymex) | USD/bbl. | 60.19 | -0.41% |
| Brent Crude (ICE) | USD/bbl. | 65.93 | -0.32% |
| Gold Spot | USD/t oz. | 1,485 | 0.5% |
| Copper (Comex) | USd/lb. | 280 | -0.3% |
Click graph to enlarge
UK 100 called to open -22 points at 7570; This on the back of a positive trading session in Asia, that saw stocks drift near record highs. The Nikkei closed at 23,821 (+5 points), while the Hang Seng closed at 27,855 (-15 points) This follows the U.S closing out last week with fresh record highs, the Dow Jones closing at 28,455 (+78 points), the S&p 500 closing at 3,221 (+15 points) and the Nasdaq closing at 8.924 (+37 points). Oil extended losses after the biggest decline in three weeks as Kuwait signalled a deal with Saudi Arabia to renew crude output along their border and as U.S. shale explorers increased drilling, Crude trades at $66.17 at time of writing. Whilst gold found some positive momentum to trade up to $1484 at time of writing.
Anglo American announces that it has received the next phase of its operating licence for its Minas-Rio tailings facility in Brazil.
AstraZeneca today announced that budesonide/glycopyrronium/formoterol fumarate has been approved in China for the maintenance treatment of chronic obstructive pulmonary disease (COPD).
AstraZeneca have also announced that the US FDA has approved Enhertu for the treatment of adult patients with unresectable or metastatic HER2-positive breast cancer who have received two or more prior anti-HER2 based regimens in the metastatic setting.
BHP announce that their CEO Andrew Mackenzie will retire on the 31st of March 2020.
Cobham are to be acquired in a cash by US company Advent for $5bn after UK authorities approved the deal.
GlaxoSmithKline subsidiary ViiV Healthcare received a complete response letter from the US Food and Drug Administration regarding its application for cabotegravir and rilpivirine long-acting regimen for treatment of HIV-1 infection. There have been no reported safety issues related to Chemistry Manufacturing and Controls.
Intu Properties announces the disposal of Intu Puerto Venecia shopping centre to Generali Shopping Centre Fund S.C.S. SICAV-SIF and Union Investment Real Estate GMBH for €475.3 million (intu share €237.7 million).
NMC Health announce that they are to commence an independent, third party review of the business to reassure shareholders as they believe the current share price is not a fair reflection of the value of the company.
Source: Bloomberg, FT, Reuters, DJ Newswires, AlphaTerminal
None
German IFO business climate
US New home sales
UK 100
BT Group - 2.3%
British American Tobacco - 1,6%
Halma - 0.3%
Bovis Homes - 2.9%
NewRiver REIT - 2.8%
Dixons Carphone - 1.6%
Grainger - 1.2%
JP Morgan Japanese Investment Trust - 1.1%
(Full list available on Week in advance)
For any help you may require placing trades or in terms of market information, put a call in to our trading floor – it’s all part of the service.
This research is produced by Accendo Markets Limited. Research produced and disseminated by Accendo Markets is classified as non-independent research, and is therefore a marketing communication. This investment research has not been prepared in accordance with legal requirements designed to promote its independence and it is not subject to the prohibition on dealing ahead of the dissemination of investment research. This research does not constitute a personal recommendation or offer to enter into a transaction or an investment, and is produced and distributed for information purposes only.
Accendo Markets considers opinions and information contained within the research to be valid when published, and gives no warranty as to the investments referred to in this material. The income from the investments referred to may go down as well as up, and investors may realise losses on investments. The past performance of a particular investment is not necessarily a guide to its future performance.